Who is sponsoring NCT05560919?

NCT05560919 is sponsored by Tishreen University.

What drugs are being tested in NCT05560919?

Interventions in NCT05560919: Dihydroxycholecalciferols, dimethyl sulfoxide, serum.

What condition does NCT05560919 study?

NCT05560919 studies Mild to Moderate Anterior Mandibular Segment Crowdind.

Is NCT05560919 still recruiting?

NCT05560919 is currently completed. Last updated 30 September 2022.

Last reviewed 2022-09-30 · How we verify

NCT05560919

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceleration of Orthodontic Tooth Movement

Completed Phase 2, PHASE3 Last updated 30 September 2022

What this trial tests

Phase 2, PHASE3 trial testing Dihydroxycholecalciferols in Mild to Moderate Anterior Mandibular Segment Crowdind in 18 participants. Completed in 25 June 2022.

Timeline

20 September 2021

Primary endpoint
30 April 2022

25 June 2022

Quick facts

Lead sponsor	Tishreen University
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	18
Start date	20 September 2021
Primary completion	30 April 2022
Estimated completion	25 June 2022
Sites	1 location across Syria

Drugs / interventions tested

Dihydroxycholecalciferols — full drug profile →
dimethyl sulfoxide (DIMETHYL SULFOXIDE) — full drug profile →
serum — full drug profile →

Conditions studied

Mild to Moderate Anterior Mandibular Segment Crowdind — all drugs for Mild to Moderate Anterior Mandibular Segment Crowdind →

Sponsor

Tishreen University

Who can join

Adults 15 to 25, any sex, with Mild to Moderate Anterior Mandibular Segment Crowdind. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

EVALUATION OF EFFICACY OF LOCALLY INJECTED Vitamin D3 (calcitriol or 1.25 dihidroxicolecalciferol) IN ACCELERATING ORTHODONTIC MOVEMENT Design: A randomized, controlled, crossover, double-blind clinical study including Eighteen adult , aged 15-25 years old.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tishreen University trials

Trials by the same sponsor.

NCT07350421 — The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN) · NA · not yet recruiting
NCT07270042 — Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection · NA · not yet recruiting
NCT07099261 — A Comparative Clinical Study to Evaluate Crowns Designed by Artificial Intelligence Versus Crowns Designed Traditional D · NA · not yet recruiting
NCT07467759 — Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy · Phase 4 · completed
NCT07095946 — Effectiveness of Intraligament vs IANB Anesthesia in Children Using Electronic Syringe · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05560919 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tishreen University
Last refreshed: 30 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05560919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing